Hardyz Pharmaceuticals Private Limited

Hardyz Pharmaceuticals Private Limited - business services in Pune, Maharashtra, India. Directors, charges & compliance details.
CIN U46497PN2023PTC222040 Incorporated 10 July 2023 ROC Pune HQ Pune, Maharashtra, India
Active Private Limited Company
Data last updated
Revenue · FY 2025
₹22.3 Lakh
▲ 287% YoY
Net profit · FY 2025
₹24,145
Net margin 1.1%
EBITDA · FY 2025
₹24,169
EBITDA margin 1.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Hardyz Pharmaceuticals Private Limited

Data last updated:

Hardyz Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It was incorporated on 10 July 2023.

The company is registered with the Registrar of Companies (ROC), Pune, under CIN U46497PN2023PTC222040.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Narayan Atole and Shivani Ravi Atole.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹22.3 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹24,145 (net margin 1.1%) and EBITDA of ₹24,169 (EBITDA margin 1.1%).

Company details

CIN U46497PN2023PTC222040
Registration Number 222040
Incorporation Date 10 July 2023
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Hardyz Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.

  • Registered Address
    Gat No.1147 Flat No.301, Dalvi Complex Haveli, Pune, Maharashtra, India – 412207
Comprehensive company report
Hardyz Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Hardyz Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Hardyz Pharmaceuticals Private Limited, buy the company report.

Financials of Hardyz Pharmaceuticals Private Limited

FY 2025 filings available

Hardyz Pharmaceuticals Private Limited reported revenue of ₹22.3 Lakh (up 287% YoY) for FY 2025.

Revenue · FY 2025
₹22.3 Lakh ▲ 287%
Net profit · FY 2025
₹24,145 margin 1.1%
EBITDA · FY 2025
₹24,169 margin 1.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 287%
EBITDA CAGR growth
1 year
▲ 195%

Revenue rose 287% in the latest year. EBITDA rose 195% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹24,169
Profit Before Tax
Tax Expense
Net Profit (PAT)₹24,145
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin1.1%
Net Profit Margin1.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hardyz Pharmaceuticals Private Limited, buy the company report.

Board of directors of Hardyz Pharmaceuticals Private Limited

Hardyz Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ravi Narayan AtoleDirector10 Jul 20233 Years 3 MonthsCurrent
Shivani Ravi AtoleDirector10 Jul 20233 Years 3 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hardyz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Hardyz Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Hardyz Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Ravi Narayan Atole was appointed as Director on 10 Jul 2023.

AGM
Hardyz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hardyz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Ravi Narayan Atole was appointed as Director.
Appointed
Shivani Ravi Atole was appointed as Director.
Incorporation
10 Jul 2023
Hardyz Pharmaceuticals Private Limited was registered on 10 Jul 2023 with Roc Pune & aged 3 years 3 months as per MCA records.

Frequently asked questions

Hardyz Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. It was incorporated on 10 July 2023 (3+ years old) and is registered under CIN U46497PN2023PTC222040.

Hardyz Pharmaceuticals has 2 current directors:

The latest financial statements of Hardyz Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Hardyz Pharmaceuticals is U46497PN2023PTC222040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hardyz Pharmaceuticals was incorporated on 10 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Pune.

Ravi Narayan Atole was appointed as Director on 10 Jul 2023. Shivani Ravi Atole was appointed as Director on 10 Jul 2023.

The registered office of Hardyz Pharmaceuticals is at Gat No.1147 Flat No.301, Dalvi Complex Haveli, Pune, Maharashtra, India – 412207.

Hardyz Pharmaceuticals can be reached at its registered office: Gat No.1147 Flat No.301, Dalvi Complex Haveli, Pune, Maharashtra, India – 412207.

Hardyz Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.